Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amplification of external sound via deep canal microphone placement" refers to a hearing aid design technique, not a biological molecule or receptor. It involves positioning the microphone deep within the ear canal to leverage the natural acoustic amplification provided by the pinna (outer ear) and ear canal, which boosts high-frequency sounds (2000-5000 Hz) by 5-8 dB compared to behind-the-ear (BTE) placements.[1] This placement enhances speech intelligibility, directivity (better front-to-back sound discrimination), sound localization via head-related transfer functions, and reduces wind noise and feedback.[1][3] Examples include ExSilent's MaRiC (Microphone and Receiver in Canal) in the Ytango device and Mic-in-Helix (MIH) instruments, which connect a canal module to an over-the-ear processor.[1][3] These approaches improve performance in noise without increasing electronic gain, allowing smaller devices with lower power use and open-fit comfort.[1][3] No drugs interact with this as it is a hardware feature for hearing loss management, not a therapeutic target like enzymes or receptors.[1][2][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deep canal microphone placement.